IMI plc (LON:IMI – Get Free Report) shares crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 1,631.01 ($20.47) and traded as high as GBX 1,831 ($22.99). IMI shares last traded at GBX 1,815 ($22.78), with a volume of 512,407 shares.
Analyst Ratings Changes
IMI has been the topic of a number of research analyst reports. Royal Bank of Canada reiterated an “outperform” rating and issued a GBX 2,150 ($26.99) target price on shares of IMI in a research note on Thursday, February 29th. JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a GBX 1,850 ($23.22) price objective on shares of IMI in a report on Thursday, December 14th. Finally, Berenberg Bank reissued a “buy” rating and set a GBX 1,950 ($24.48) price target on shares of IMI in a report on Monday, March 4th.
View Our Latest Stock Report on IMI
IMI Stock Performance
IMI Increases Dividend
The company also recently disclosed a dividend, which will be paid on Friday, May 17th. Investors of record on Thursday, April 4th will be issued a dividend of GBX 19.20 ($0.24) per share. The ex-dividend date is Thursday, April 4th. This represents a yield of 1.11%. This is a boost from IMI’s previous dividend of $9.10. IMI’s payout ratio is currently 3,010.75%.
Insider Activity at IMI
In other IMI news, insider Roy Twite sold 57,067 shares of IMI stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of GBX 1,819 ($22.83), for a total value of £1,038,048.73 ($1,303,099.08). Corporate insiders own 1.41% of the company’s stock.
IMI Company Profile
IMI plc, a specialist engineering company, designs and manufactures engineering products in the United Kingdom, Germany, rest of Europe, the United States of America, rest of the Americas, China, rest of Asia Pacific, the Middle East, and Africa. It operates through IMI Precision Engineering, IMI Critical Engineering, and IMI Hydronic Engineering segments.
Featured Stories
- Five stocks we like better than IMI
- 3 Stocks to Consider Buying in October
- What is a Bull Market? Key Information about Bull Markets
- Why Invest in 5G? How to Invest in 5G Stocks
- Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
- What are earnings reports?
- Dave & Buster’s Stock Value Is Unleashed, Not Too Late To Get In
Receive News & Ratings for IMI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMI and related companies with MarketBeat.com's FREE daily email newsletter.